EFDID: 558809EFD: View Filing

Issuer: Maxona Pharmaceuticals, Inc. (0001857448) - D

Accession: 0001857448-25-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001857448
  • Entity Name:
    Maxona Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    101 Lindenwood Drive
    Suite 225
    Malvern, PA 19355
  • Persons:
    Related Persons 4
    Shahin Fatholahi
    Executive Officer, Director
    Behshad Sheldon
    Director
    David Nakamura
    Director
    Richard Brand
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    06/13/2025
  • First Sale Date:
    06/04/2025
  • Offering Amount:
    $5,000,000
  • Amount Sold:
    $900,163
  • Amount Remaining:
    $4,099,837
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AZ, CA, CO, CT, NV, NY, PA, TN, TX, WI
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Arcadia Securities, LLC 44656 None None AZ, CA, CO, CT, FL, NV, NY, PA, RI, TN, TX, WI
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Maxona Pharmaceuticals, Inc.Shahin FatholahiShahin FatholahiChief Executive Officer2025-06-13